Exdeo Clinical Research Inc.
Abbotsford British Columbia, British Columbia V2T 1X8
0 studies enrolling now · 3 studies all time
What they study most
Interstitial Cystitis, Non-muscle Invasive Bladder Cancer, Urinary Bladder Neoplasms
Studies at this site
- Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer — Recruiting now
- A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy — Running, not enrolling
- Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis — Stopped early